Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 10,386.00p on 28-05-2025 at 18:40:05
Change -98.00p -0.93%
Buy 10,388.00p
Sell 10,384.00p
Buy / Sell AZN Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 18.00 at 10,386.00p
Day's Volume: 1,144,085
Last Close: 10,386.00p
Open: 10,468.00p
ISIN: GB0009895292
Day's Range 10,366.00p - 10,500.00p
52wk Range: 9,574.00p - 13,338.00p
Market Capitalisation: £161,003m
VWAP: 10,402.66428p
Shares in Issue: 1,550m

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 18 10,386.00p Automatic Execution
 16:38:22 - 28-May-25
Sell* 416 10,386.00p Automatic Execution
 16:38:16 - 28-May-25
Sell* 184 10,386.00p Automatic Execution
 16:38:16 - 28-May-25
Sell* 816 10,386.00p Automatic Execution
 16:38:14 - 28-May-25
Sell* 384 10,386.00p Automatic Execution
 16:38:14 - 28-May-25
Buy* 32,490 10,396.74786p SI Trade
Negotiated Trade
 16:37:49 - 28-May-25
Sell* 6 10,386.00p Automatic Execution
 16:37:32 - 28-May-25
Sell* 600 10,386.00p Automatic Execution
 16:37:31 - 28-May-25
Buy* 10 10,386.00p Automatic Execution
 16:37:23 - 28-May-25
Sell* 980 10,386.00p Automatic Execution
 16:35:45 - 28-May-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
28th May 2025 (Wed) 10,468.00 10,500.00 10,366.00 10,386.00 1,144,085
27th May 2025 (Tue) 10,490.00 10,598.00 10,464.00 10,484.00 1,148,802
26th May 2025 (Mon) 10,446.5752 10,446.5752 10,446.5752 10,446.5752 75,885
23rd May 2025 (Fri) 10,476.00 10,514.00 10,288.00 10,436.00 3,120,737
22nd May 2025 (Thu) 10,410.00 10,486.00 10,334.00 10,374.00 1,081,196
21st May 2025 (Wed) 10,390.00 10,556.00 10,376.00 10,492.00 3,963,410
20th May 2025 (Tue) 10,440.00 10,512.00 10,348.00 10,418.00 2,290,334
19th May 2025 (Mon) 10,324.00 10,372.00 10,212.00 10,372.00 2,529,943
16th May 2025 (Fri) 10,230.00 10,374.00 10,216.00 10,330.00 4,844,247
15th May 2025 (Thu) 9,946.00 10,228.00 9,932.00 10,142.00 2,520,323
14th May 2025 (Wed) 10,164.00 10,252.00 10,010.00 10,022.00 3,887,993
13th May 2025 (Tue) 10,354.00 10,394.00 10,164.00 10,180.00 1,526,868
12th May 2025 (Mon) 9,743.00 10,320.00 9,651.00 10,272.00 3,037,101
9th May 2025 (Fri) 10,140.00 10,328.00 10,132.00 10,240.00 2,846,036
8th May 2025 (Thu) 10,406.00 10,428.00 10,100.00 10,134.00 2,287,586
7th May 2025 (Wed) 10,478.00 10,554.00 10,392.00 10,504.00 3,690,675
6th May 2025 (Tue) 10,890.00 10,902.00 10,674.00 10,700.00 2,983,792
5th May 2025 (Mon) 10,885.1479 10,885.1479 10,885.1479 10,885.1479 6,765
2nd May 2025 (Fri) 10,656.00 10,790.00 10,600.00 10,754.00 2,368,624
1st May 2025 (Thu) 10,766.00 10,778.00 10,444.00 10,608.00 1,222,578
30th Apr 2025 (Wed) 10,820.00 10,892.00 10,676.00 10,728.00 3,299,474
29th Apr 2025 (Tue) 10,050.00 10,620.00 9,978.00 10,618.00 2,494,155
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
27th May 2025 7:00 am RNS Imfinzi recommended in EU for bladder cancer
23rd May 2025 10:00 am RNS Director/PDMR Shareholding
21st May 2025 1:45 pm RNS Director Declaration
20th May 2025 7:00 am RNS Acquisition of EsoBiotec completed
9th May 2025 7:00 am RNS Imfinzi improved DFS in early bladder cancer
7th May 2025 7:30 am RNS Enhertu improved pCR in early-stage breast cancer
6th May 2025 7:00 am RNS Calquence combination approved in EU for 1L MCL
2nd May 2025 7:00 am RNS Breztri met primary endpoints in Ph3 asthma trials
1st May 2025 4:00 pm RNS Director/PDMR Shareholding
1st May 2025 3:00 pm RNS Total Voting Rights
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

Angle shares fall on weak 2025 outlook despite narrower annual loss

28th May 2025 13:31

(Alliance News) - Angle PLC on Wednesday said its annual loss narrowed in 2024 as revenue rose and operating costs fell, though the company warned that market uncertainty and funding cuts were weighing on revenue so far this year. Read More

LONDON BROKER RATINGS: RBC cuts National Grid; Citigroup cuts South32

28th May 2025 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: Tariff optimism, US data lifts FTSE 100

27th May 2025 17:10

(Alliance News) - Stock prices in Europe ended largely higher on Tuesday, building on a confident start to the week, while equities in London also got in on the action following Monday's public holiday. Read More

AstraZeneca bladder cancer drug Imfinzi recommended for EU approval

27th May 2025 08:36

(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi, or durvalumab, therapy has been recommended for approval in the EU for the treatment of muscle-invasive bladder cancer. Read More

LONDON BRIEFING: Bodycote revenue falls; Inspired mulls possible offer

27th May 2025 07:56

(Alliance News) - London's FTSE 100 is called higher on Tuesday following a bank holiday-lengthened weekend, as Nato members are expected to raise defence spending to 5% of output. Read More

See more Astrazeneca news
FTSE 100 Latest
Value8,726.01
Change-52.04

Login to your account

Forgot Password?

Not Registered